SERA PROGNOSTICS, INC. - Class A Common Stock $0.0001 par value per share (SERA)

CUSIP: 81749D107

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 6 signals
Share change
+42,355
SEC-reported price per share
$1.60
Number of holders
31
Value change
+$64,785
Number of buys
17
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,190,361

Security key

81749D107

Report period

Q3 2022

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of SERA - SERA PROGNOSTICS, INC. - Class A Common Stock $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Blue Ox Healthcare Partne...
Disclosed value leader
INTERWEST VENTURE MANAGEM...
Comparable rows
0/15
Latest evidence
18 Jul 2022
3/4/5 13F Highest disclosed value: $3,963,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

INTERWEST VENTURE MANAGEMENT CO has the largest disclosed position value at $3.96M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTERWEST VENTURE MANAGEMENT CO's linked filing trail.
Disclosed position value Top 5
Blue Ox Healthcare Partners, LLC $1.34M
INTERWEST VENTURE MANAGEMENT CO $3.96M
Vivo Capital, LLC $3.04M
SANDERS MORRIS HARRIS LLC $1.99M
Parian Global Management LP $1.18M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Blue Ox Healthcare Partners, LLC
3/4/5
10%+ Owner
—
denominator unverified
$1,339,791
256,665 shares
— 18 Jul 2022
INTERWEST VENTURE MANAGEMENT CO
13F
Company
13F
—
denominator unverified
$3,963,000
2,416,241 shares
— 30 Jun 2022
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$3,044,000
1,856,011 shares
— 30 Jun 2022
SANDERS MORRIS HARRIS LLC
13F
Company
13F
—
denominator unverified
$1,989,000
1,212,823 shares
— 30 Jun 2022
Parian Global Management LP
13F
Company
13F
—
denominator unverified
$1,181,000
719,986 shares
— 30 Jun 2022
Douglas Carl Fisher
3/4/5
Chief Business Officer
—
denominator unverified
$1,151,334
220,562 shares
— 10 Jan 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
8,696,925
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q4 2025 Across Filers

Q4 2025 holders
56
Q3 2022 holders
31
Holder diff
-25
Investor Q4 2025 Shares Q3 2022 Shares Share Diff Share Chg % Q4 2025 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .